Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-02-14Clinical Trial Update: Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery [Phase 3]
Phase 3 trial evaluating chemotherapy with or without bevacizumab in patients with resected stage IB-IIIA non-small cell lung cancer. Result…
-
CLINICAL_TRIALS trial_result · 2018-02-14Clinical Trial Update: Osimertinib or Docetaxel-bevacizumab as Third-line Treatment in EGFR T790M Mutated Non-Small Cell Lung Cancer [Phase 2, Phase 3]
A clinical trial comparing osimertinib versus docetaxel-bevacizumab as third-line therapy for EGFR T790M-mutated non-small cell lung cancer …
-
CLINICAL_TRIALS trial_result · 2018-02-14Clinical Trial Update: Comparison of Veliparib and Whole Brain Radiation Therapy (WBRT) Versus Placebo and WBRT in Adults With Brain Metastases From Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial comparing veliparib plus whole-brain radiation therapy to placebo plus whole-brain radiation therapy in adults with brain me…
-
CLINICAL_TRIALS trial_result · 2018-02-07Clinical Trial Update: Uncommon EGFR AZD9291 [Phase 2]
Phase 2 clinical trial update for an EGFR-directed therapy (AZD9291) in non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2018-02-07Clinical Trial Update: Docetaxel With or Without TAK-117 (MLN1117) in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluating docetaxel with or without TAK-117 (MLN1117) in locally advanced or metastatic non-small cell lung cancer; the s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-02-05Clinical Trial Update: A Study of Bevacizumab Versus Placebo in Combination With Carboplatin/Paclitaxel in Participants With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Previous Chemotherapy [Phase 3]
Phase 3 trial comparing bevacizumab plus carboplatin/paclitaxel versus placebo in advanced or recurrent non-squamous non-small cell lung can…
-
CLINICAL_TRIALS trial_result · 2018-01-31Clinical Trial Update: Apatinib Plus Docetaxel in Advanced Non-squamous Non-small Cell Lung Cancer(NSCLC) [Phase 2]
Phase 2 trial update evaluating apatinib plus docetaxel in advanced non-squamous non-small cell lung cancer (NSCLC).
-
CLINICAL_TRIALS trial_result · 2018-01-30Clinical Trial Update: A Study of Erlotinib Plus Radiotherapy (RT) for Patients With Advanced or Inoperable Non-Small-Cell Lung Cancer [Phase 2]
Phase 2 study evaluating erlotinib in combination with radiotherapy for patients with advanced or inoperable non-small cell lung cancer; the…
-
CLINICAL_TRIALS trial_result · 2018-01-30Clinical Trial Update: Ganetespib and Ziv-Aflibercept in Refractory Gastrointestinal Carcinomas, Non-Squamous Non-Small Cell Lung Carcinomas, Urothelial Carcinomas, and Sarcomas [Phase 1]
Phase 1 study of ganetespib with ziv-aflibercept in refractory gastrointestinal cancer, non-small cell lung cancer (non-squamous), urothelia…
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: Study of Patritumab in Combination With Erlotinib in Subjects With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC). (HER3-Lung) [Phase 3]
Phase 3 study of patritumab with erlotinib in locally advanced or metastatic non-small cell lung cancer was terminated with results posted i…
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: Induction Therapy With Intercalated Tyrosine Kinase Inhibitor (TKI) and Chemotherapy in NSCLC With Activating Epidermal Growth Factor Receptor (EGFR) Mutation in Stages II-IIIB [Phase 2, Phase 3]
A phase 2/3 clinical trial evaluating induction therapy combining an intercalated tyrosine kinase inhibitor with chemotherapy for NSCLC pati…
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: A Clinical Research of NK Cell Infusion Combined With Chemotherapy in the Treatment of Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial investigating NK cell infusion combined with chemotherapy for non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2018-01-18Clinical Trial Update: Icotinib Combined With Dihydroaremisinin (DHA) Therapy in Patients With Advanced NSCLC [Phase 2]
Phase 2 clinical trial evaluating icotinib plus dihydroaremisinin (DHA) in EGFR-positive non-small cell lung cancer with adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2018-01-18Clinical Trial Update: A Trial With Metronomic Low-dose Treosulfan, Pioglitazone and Clarithromycin Versus Standard Treatment in NSCLC [Phase 2]
Phase 2 clinical trial evaluating metronomic low-dose treosulfan, pioglitazone, and clarithromycin versus standard treatment in non-small ce…
-
CLINICAL_TRIALS trial_result · 2018-01-17Clinical Trial Update: Strategies for Maintenance Therapies in Advanced Non Small Cell Lung Cancer [Phase 3]
Phase 3 clinical trial update on maintenance therapies for advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2018-01-17Clinical Trial Update: A Study of Apatinib Plus Docetaxel for Treatment of Advanced Non-squamous Non-small Cell Lung Cancer With Bone Metastases [Phase 2]
Phase 2 trial update of apatinib plus docetaxel for advanced non-squamous non-small cell lung cancer with bone metastases.
-
CLINICAL_TRIALS trial_result · 2018-01-16Clinical Trial Update: The Continuation of Gefitinib Treatment Beyond Progression in Non-small Cell Lung Cancer Patients With EGFR Mutation [Phase 2]
Phase 2 trial update evaluating continuing gefitinib after progression in EGFR-mutated non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2018-01-16Clinical Trial Update: Genetic Sequencing-Informed Targeted Therapy in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer [NA]
Clinical trial evaluating genetic sequencing-informed targeted therapy for stage IIIB-IV non-small cell lung cancer has been terminated with…
-
CLINICAL_TRIALS trial_result · 2018-01-10Clinical Trial Update: OSI-774 (Tarceva) in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 3]
Phase 3 trial update of Tarceva (OSI-774) in stage III/IV non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2018-01-09Clinical Trial Update: Stereotactic Radiosurgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer [NA]
This terminated clinical trial evaluated stereotactic radiosurgery for stage I/II non-small cell lung cancer and had its results posted in 2…
-
CLINICAL_TRIALS trial_result · 2018-01-04Clinical Trial Update: A Study Evaluates the Safety, Pharmacokinetics and Efficacy of WX-0593 in Advanced Solid Tumor Patients [Phase 1, Phase 2]
A clinical trial update evaluating WX-0593 in advanced solid tumors and non-small cell lung cancer across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2018-01-03Clinical Trial Update: A Global Study to Assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer [Phase 2]
A Phase 2 global trial evaluating durvalumab (MEDI4736) in locally advanced or metastatic non-small cell lung cancer has completed, with res…
-
CLINICAL_TRIALS trial_result · 2018-01-03Clinical Trial Update: Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLC [Phase 2]
Phase 2 clinical trial update evaluating apatinib for EGFR T790M-negative non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2017-12-28Clinical Trial Update: Efficacy and Safety of Oral Treatment With BIBF 1120 ES in Advanced Non-small-cell Lung Cancer [Phase 2]
Phase 2 trial assessing efficacy and safety of oral BIBF 1120 ES in advanced non-small-cell lung cancer completed.
-
CLINICAL_TRIALS trial_result · 2017-12-22Clinical Trial Update: Pembrolizumab (MK-3475) as Maintainance in Treated Patients With Unresectable Stage III NSCLC [Phase 2]
Phase 2 trial update evaluating pembrolizumab as maintenance therapy in treated patients with unresectable stage III non-small cell lung can…